APTIVUS 250 mg, soft capsule 120 capsules
Active ingredients: Tipranavir
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule120 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APTIVUS 250 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Dec 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67219072CIP73692524CIP133400936925243Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TIPRANAVIRcapsule | 250 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.